Hepion Pharmaceuticals, Inc

/Hepion Pharmaceuticals, Inc

FOLLOW-ON OFFERING: We are a biopharmaceutical company headquartered in Edison, New Jersey, focused on the development of pleiotropic drug therapy for treatment of chronic liver disease.


Last Closing Price


Anticipated Date
November 25, 2020


This offering is no longer available

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange